GLP-1/FGF21 mesenchymal stem cells

人GLP-1和FGF21双因子高表达脂肪干细胞

Report date: 2026/04/03 20:03:44

Base Information

Drug NameGLP-1/FGF21 mesenchymal stem cells
Drug Alias Name人 GLP-1 和 FGF21 双因子高表达自体脂肪间充质干细胞人GLP-1和FGF21双因子高表达脂肪干细胞
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacementsFibroblast growth factor 21 agonistsGlucagon-like peptide 1 receptor agonists
TargetsFibroblast growth factor 21Glucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Jiyuan Biological Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Jiyuan Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A